TMCnet News
U.S. Patents Awarded to Inventors in New Jersey (May 24)(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., May 24 -- The following federal patents were awarded to inventors in New Jersey. *** L-3 Communications Mobile-Vision Assigned Patent ALEXANDRIA, Va., May 24 -- L-3 Communications Mobile-Vision, Boonton, N.J., has been assigned a patent (8,446,469) developed by Louis W. Blanco, Boonton, N.J., and Leo Lorenzetti, Hardyston, N.J., for a "wireless microphone for use with an in-car video system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An in-car video system and method is provided where a wireless microphone is configured with bi-directional communications capability. In response to a received RF activation signal, the wireless microphone is automatically switched on to capture (and transmit back to the in-car video system) an audio soundtrack that accompanies the images captured by the car-mounted video camera. A wireless microphone controller mounted in the car transmits the RF activation signal to the wireless microphone. The wireless microphone controller is arranged to transmit the RF activation signal when the VCR starts recording. In an illustrative embodiment of the invention, the wireless microphone receives information, including a confirmation that the VCR is recording, from an RF information signal received from the wireless microphone controller mounted in the car. The wireless microphone displays the information to the officer on a display screen. The wireless microphone sounds an audible alert when it receives the RF activation or information signals." The patent application was filed on Oct. 6, 2006 (11/544,837). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,446,469&OS=8,446,469&RS=8,446,469 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Visam Development Assigned Patent ALEXANDRIA, Va., May 24 -- Visam Development, Wilmington, Del., has been assigned a patent (8,446,394) developed by Roger Stewart, Hillsborough, N.J., for "pixel circuits and methods for driving pixels." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A display driver according to one embodiment includes a digital to analog converter producing a current at a selected level an output of the digital to analog converter being coupleable to a data line of a display; and a voltage source being coupleable to the data line for precharging the data line. A method for precharging a data line of a display according to another embodiment includes determining a voltage level on a data line during a frame period; storing the voltage level; and prior to or during a subsequent frame period, precharging the data line voltage to a derivative of the stored voltage level. Additional systems and methods are claimed." The patent application was filed on June 7, 2007 (11/759,817). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,446,394&OS=8,446,394&RS=8,446,394 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Thomas Jefferson University Assigned Patent ALEXANDRIA, Va., May 24 -- Thomas Jefferson University, Philadelphia, has been assigned a patent (8,445,650) developed by Lance L. Simpson, Moorestown, N.J., and Mohammed Elias, Voorhees, N.J., for a "mutant botulinum neurotoxin serotype A polypeptide and uses thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Modified polypeptides based on the botulinum neurotoxin A heavy chain containing the double mutation Trp-Tyr->Leu-Ser in the ganglioside binding motif Ser-X-Trp-Tyr do not bind polysialogangliosides and nerve endings. The polypeptides are useful in the preparation of nontoxic vaccines against the effects of C. botulinum infection. The modified polypeptides are also useful as vehicles for the transepithelial delivery of diagnostic and therapeutic entities, through formation of conjugates between the polypeptides and the diagnostic or therapeutic entities." The patent application was filed on Sept. 25, 2008 (12/679,936). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,45,650.PN.&OS=PN/84,45,650&RS=PN/84,45,650 Written by Amal Ahmed; edited by Jaya Anand. *** ExxonMobil Research and Engineering Assigned Patent ALEXANDRIA, Va., May 24 -- ExxonMobil Research and Engineering, Annandale, N.J., has been assigned a patent (8,445,620) developed by seven co-inventors for "elastic propylene-alpha-olefin copolymer compositions and processes to produce them." The co-inventors are Andy Haishung Tsou, Allentown, Pa., Gabor Kiss, Hampton, N.J., Robert Patrick Reynolds Jr., Clinton, N.J., John W. Chu, Neshanic Station, N.J., Alan Anthony Galuska, Huffman, Texas, Patrick Brant, Seabrook, Texas, and Donald Andrew Winesett, Houston. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided are elastic propylene-alpha olefin blocky copolymers. In one form, the elastic propylene-alpha olefin blocky copolymer includes an .alpha.-olefin content from 12 to 25 wt % and having a propylene crystallinity less than 30 J/g, a Tm <100.degree. C. and a Tg >-45.degree. C., wherein said copolymer has blocky propylene segments with r.sub.1r.sub.2 greater than 1.5, and a process for producing such copolymer." The patent application was filed on Aug. 4, 2011 (13/198,201). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,45,620.PN.&OS=PN/84,45,620&RS=PN/84,45,620 Written by Amal Ahmed; edited by Jaya Anand. *** Tyrx Assigned Patent ALEXANDRIA, Va., May 24 -- Tyrx, Monmouth Junction, N.J., has been assigned a patent (8,445,603) developed by five co-inventors for "linear polyesteramides from aminophenolic esters." The co-inventors are Arthur Schwartz, East Windsor, N.J., Satish Pulapura, Bridgewater, N.J., Sarita Nethula, Somerset, N.J., Archana Rajaram, Monmouth Junction, N.J., and Arikha Moses, New York. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to linear, biodegradable polyesteramide (PEA) polymers synthesized with repeating units derived from aminophenol esters and diacids. These PEAs have a monomer repeat represented by ##STR00001## as well as a variety of uses to coat, form or comprise medical devices, combination medical devices and pharmaceutical compositions, including sustained release formulations." The patent application was filed on Sept. 22, 2009 (12/564,736). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,45,603.PN.&OS=PN/84,45,603&RS=PN/84,45,603 Written by Amal Ahmed; edited by Jaya Anand. *** AT&T Intellectual Property I Assigned Patent ALEXANDRIA, Va., May 24 -- AT&T Intellectual Property I, Atlanta, has been assigned a patent (8,446,462) developed by four co-inventors for a "method and system for time-multiplexed shared display." The co-inventors are Behzad Shahraray, Holmdel, N.J., David Gibbon, Lincroft, N.J., Zhu Liu, Marlboro, N.J., and Bernard Renger, New Providence, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method is provided for sharing a display. The method includes displaying periodically a first image sequence on the display in synchronicity with a first signal, and displaying periodically a second image sequence on the display in synchronicity with a second signal. The method also includes selecting by a user the first image sequence for viewing, and shuttering periodically a set of goggles for the user in synchronicity with the first signal. A method is provided for sharing a display. The method includes displaying periodically a private image sequence on the display in synchronicity with a first signal, and displaying periodically a non-private image sequence on the display. In the method, the private image sequence and the non-private image sequence combine to form a public image sequence on the display. A system is provided for sharing a display." The patent application was filed on Oct. 15, 2009 (12/579,937). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,446,462&OS=8,446,462&RS=8,446,462 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Siemens Industry Assigned Patent ALEXANDRIA, Va., May 24 -- Siemens Industry, Alpharetta, Ga., has been assigned a patent (8,446,285) developed by Karen D. Lontka, Randolph, N.J., for "methods and apparatus for controlling and testing a notification appliance circuit." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An arrangement for use in a safety notification system includes a source of negative voltage, a first resistor arrangement, and a circuit arrangement. The first resistor arrangement is coupled between the source of negative voltage and the signal output of the safety notification system. The circuit arrangement is configured to detect a first voltage at the signal output of the safety notification system, and to generate a trouble signal output if the first voltage at the signal output is above a first threshold or below a second threshold." The patent application was filed on Feb. 6, 2009 (12/322,851). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,446,285&OS=8,446,285&RS=8,446,285 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Bristol-Myers Squibb, Albany Molecular Research Assigned Patent ALEXANDRIA, Va., May 24 -- Bristol-Myers Squibb, Princeton, N.J., and Albany Molecular Research, Albany, N.Y., have been assigned a patent (8,445,494) developed by four co-inventors for a "crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyrida- zin-3-amine." The co-inventors are Jun Qiu, Kendall Park, N.J., Qi Gao, Franklin Park, N.J., Shuang Liu, Schenectady, N.Y., and Matthew Isherwood, Del Mar, N.Y. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present disclosure generally relates to a crystalline form of 6-[(4S)-2-methyl-4-(naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazi- n-3-amine. The present disclosure also generally relates to pharmaceutical compositions comprising the crystalline form, as well of methods of using a crystalline form in the treatment of depression and other conditions and methods for obtaining such crystalline form." The patent application was filed on June 4, 2009 (12/995,771). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,45,494.PN.&OS=PN/84,45,494&RS=PN/84,45,494 Written by Amal Ahmed; edited by Jaya Anand. *** H. Lundbeck Assigned Patent ALEXANDRIA, Va., May 24 -- H. Lundbeck, Valby, Denmark, has been assigned a patent (8,440,837) developed by five co-inventors for a "2-substituted-ethynylthiazole derivatives and uses of same." The co-inventors are Allen Hopper, Katonah, N.Y., Anette Graven Sams, Vaerlose, Denmark, Gitte Kobberoee Mikkelsen, Ballerup, Denmark, Mathivanan Packiarajan, Saddle Brook, N.J., and Michel Grenon, Saddle Brook, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides 2-substituted-ethynylthiazole derivatives of formula (I): ##STR00001## wherein R.sup.1, R.sup.2 and X are as defined herein, or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and methods of using same." The patent application was filed on Oct. 20, 2010 (12/908,588). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,440,837.PN.&OS=PN/8,440,837&RS=PN/8,440,837 Written by Kusum Sangma; edited by Anand Kumar. *** Wyeth Assigned Patent ALEXANDRIA, Va., May 24 -- Wyeth, Madison, N.Y., has been assigned a patent (8,445,496) developed by four co-inventors for "crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-pipera- zinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same." The co-inventors are Marc Sadler Tesconi, Monroe, N.Y., Gregg Feigelson, Chester, N.Y., Henry Strong, Somerset, N.J., and Hong Wen, North Potomac, Md. The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention is directed to a crystalline 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-pipera- zinyl)propoxy]-3-quinolinecarbonitrile monohydrate having an x-ray diffraction pattern wherein 2.theta. angles (.degree.) of significant peaks are at about: 9.19, 11.48, 14.32, 19.16, 19.45, 20.46, 21.29, 22.33, 23.96, 24.95, 25.29, 25.84, 26.55, 27.61, and 29.51, and a transition temperature of about 109.degree. C. to about 115.degree. C." The patent application was filed on June 22, 2010 (12/820,306). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,45,496.PN.&OS=PN/84,45,496&RS=PN/84,45,496 Written by Amal Ahmed; edited by Jaya Anand. *** Merck Sharp & Dohme Assigned Patent ALEXANDRIA, Va., May 24 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,445,538) developed by five co-inventors for "glucagon receptor antagonist compounds." The co-inventors are Songnian Lin, Monroe, N.J., Xibin Liao, Edison, N.J., Roman Kats-Kagan, Brooklyn, N.Y., John E. Stelmach, Westfield, N.J., and Emma R. Parmee, Scotch Plains, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included." The patent application was filed on Dec. 9, 2009 (13/140,260). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,45,538.PN.&OS=PN/84,45,538&RS=PN/84,45,538 Written by Amal Ahmed; edited by Jaya Anand. *** Merck Sharp & Dohme Assigned Patent ALEXANDRIA, Va., May 24 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,445,499) developed by six co-inventors for "bipiperidinyl compounds, compositions, containing such compounds and methods of treatment." The co-inventors are Harold B. Wood, Westfield, N.J., Alan D. Adams, Holland, N.Y., Stanley Freeman, Plainsboro, N.J., Jason W. Szewczyk, New York, Conrad Santini, Lawrence, Kan., and Yong Huang, West Windsor, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Bipiperidinyl compounds of the formula: ##STR00001## are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119." The patent application was filed on March 21, 2012 (13/426,418). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,45,499.PN.&OS=PN/84,45,499&RS=PN/84,45,499 Written by Amal Ahmed; edited by Jaya Anand. *** Merck Sharp & Dohme Assigned Patent for CETP Inhibitors Derived from Benzoxazole Arylamides ALEXANDRIA, Va., May 24 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,445,480) developed by five co-inventors for "CETP inhibitors derived from benzoxazole arylamides." The co-inventors are Julianne A. Hunt, Montclair, N.J., Ramzi F. Sweis, Franklin Park, N.J., Dooseop Kim, Westfield, N.J., Florida Kallashi, Lawrence Harbor, N.J., and Peter J. Sinclair, Scotch Plains, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds having the structure of Formula I1 including pharmaceutically acceptable salts of the compounds, are potent CETP (cholesterol ester transfer protein) inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis Atherosclerosis and its clinical consequences, coronary heart disease (CHD), stroke and penpheral vascular disease, represent a truly enormous burden to the health care systems of the industrialized world In formula I, A-B is an arylamide moiety." The patent application was filed on June 16, 2008 (12/664,757). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=84,45,480.PN.&OS=PN/84,45,480&RS=PN/84,45,480 Written by Amal Ahmed; edited by Jaya Anand. *** Honeywell International Assigned Patent for Turbomachinery Device for Both Compression and Expansion ALEXANDRIA, Va., May 24 -- Honeywell International, Morristown, N.J., has been assigned a patent (8,446,029) developed by William Joseph Smith, Morristown, N.J., Vai Man Lei, Morristown, N.J., and Mike Guidry, Morristown, N.J., for a "turbomachinery device for both compression and expansion." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A turbomachinery device operable in either a compressor mode or a turbine mode. The device includes an impeller that rotates in the same direction in both modes, and the general flow direction remains the same in both modes. An inlet flow-guiding device may be included to direct fluid into the impeller. The impeller is coupled to a motor/generator, which operates as a motor to add power to the impeller in the compressor mode, and as a generator in the turbine mode to extract mechanical power from the impeller and convert it into electrical power. An outlet flow-guiding device may also be included. The inlet and outlet flow-guiding devices can be inlet and outlet guide vanes that are variable in setting angle or are extendable and retractable into and out of the flow path, or can be other types of flow-guiding devices." The patent application was filed on April 5, 2010 (12/754,433). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,446,029.PN.&OS=PN/8,446,029&RS=PN/8,446,029 Written by Kusum Sangma; edited by Anand Kumar. *** ExxonMobil Research and Engineering Assigned Patent ALEXANDRIA, Va., May 24 -- ExxonMobil Research and Engineering, Annandale, N.J., has been assigned a patent (8,445,841) developed by five co-inventors for a "method and apparatus for a mid-infrared (MIR) system for real time detection of petroleum in colloidal suspensions of sediments and drilling muds during drilling operations, logging and production operations." The co-inventors are John S. Szobota, Morristown, N.J., James M. Brown, Flemington, N.J., Clifford C. Walters, Milford, N.J., Mark M. Disko, Glen Gardaen, N.J., and Boris Mizaikoff, Ulm, Germany. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A first waveguide has a top face positioned in an oil well borehole for wetting by returning drilling mud from a drill bit as drilling progresses. A second waveguide is positioned in the borehole for wetting by new drilling mud being pumped to the drill bit. MIR light rays are fed from an MIR light source into the first and second waveguides for causing evanescent waves to be generated by each waveguide for reacting with the molecules of the associated drilling mud, respectfully, whereby a modulated optical signal representative of spectra of components and particles in the associated drilling mud, respectively, are emitted from each waveguide. The modulated optical signals are converted to electrical signals, subtracted from one another to remove common mode signals, and passed into a processor programmed for extracting the spectra hydrocarbon components contained in the returning drilling mud as the result of the drilling activity." The patent application was filed on Dec. 8, 2011 (13/314,423). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,841&OS=8,445,841&RS=8,445,841 Written by Arpi Sharma; edited by Anand Kumar. *** Honeywell International Assigned Patent ALEXANDRIA, Va., May 24 -- Honeywell International, Morristown, N.J., has been assigned a patent (8,445,866) developed by James Kane, Lawrenceville, N.J., William Ross Rapoport, Bridgewater, N.J., and Carsten Lau, Niedersachsen, Germany, for a "refractive index matched phosphors and substrates for security applications." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Phosphor compositions are provided that can be incorporated into or onto plastic substrates as covert security features. The plastic substrates can be transparent and the phosphor compositions have a refractive index that effectively matches the refractive index of the plastic substrate to maintain the transparency. The phosphor compositions have absorption in the infrared, thus enabling excitation and detection of the compositions with an infrared emitting source." The patent application was filed on Dec. 13, 2010 (12/966,036). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,866&OS=8,445,866&RS=8,445,866 Written by Arpi Sharma; edited by Anand Kumar. *** Dow Global Technologies Assigned Patent ALEXANDRIA, Va., May 24 -- Dow Global Technologies, Midland, Mich., has been assigned a patent (8,445,786) developed by Stephen H. Cree, Hirzel, Switzerland, and David P. Wright, Somerset, N.J., for a "crosslinkable blends of polyolefin elastomers and silane copolymers for increased flexibility cable insulation." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compositions having at least 60 weight percent, based on the total weight of polymers, have at least one silane crosslinkable polyolefin resin and up to about 40 weight percent, based on the total weight of polymers, of at least one polyolefin elastomer resin, wherein the polyolefin polymer elastomer resin has density of less than or equal to about 0.89 g/cm.sup.3 and a melt index, I.sub.2, of less than about 50 g/10 mm. and which has been prepared using at least one metallocene catalyst provide improved flexibility, especially low temperature flexibility, while maintaining suitable cure performance and strength compared to the silane crosslinkable polymer resin alone. This composition may be used in cables for low temperature service applications." The patent application was filed on June 20, 2008 (12/664,703). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,786&OS=8,445,786&RS=8,445,786 Written by Arpi Sharma; edited by Anand Kumar. *** Merck Sharp & Dohme Assigned Patent ALEXANDRIA, Va., May 24 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,445,680) developed by four co-inventors for a tetrahydrothieno pyridines. The co-inventors are John S. Debenham, Scotch Plains, N.J., Jeffrey J. Hale, Westfield, N.J., Christina B. Madsen-Duggan, Scotch Plains, N.J., and Thomas F. Walsh, Watchung, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to tetrahydrothienopyridine compounds useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions." The patent application was filed on Feb. 11, 2009 (12/919,190). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,680&OS=8,445,680&RS=8,445,680 Written by Arpi Sharma; edited by Anand Kumar. *** Bristol-Myers Squibb Assigned Patent ALEXANDRIA, Va., May 24 -- Bristol-Myers Squibb, Princeton, N.J., has been assigned a patent (8,445,676) developed by five co-inventors for a pyrrolotriazine kinase inhibitors. The co-inventors are Ashok Vinayak Purandare, Pennington, N.J., David B. Frennesson, Naugatuck, Conn., Muthoni G. Kamau, Lawrenceville, N.J., Lalgudi S. Harikrishnan, Skillman, N.J., and Mark G. Saulnier, Higganum, Conn. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides compounds of formula I ##STR00001## and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of such as Jak2 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases." The patent application was filed on Oct. 8, 2009 (13/123,305). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,676&OS=8,445,676&RS=8,445,676 Written by Arpi Sharma; edited by Anand Kumar. *** HRD Assigned Patent ALEXANDRIA, Va., May 24 -- HRD, Houston, has been assigned a patent (8,445,672) developed by five co-inventors for a "high shear process for dextrose production." The co-inventors are Abbas Hassan, Sugar Land, Texas, Ebrahim Bagherzadeh, Sugar Land, Texas, Rayford G. Anthony, College Station, Texas, Gregory Borsinger, Chatham, N.J., and Aziz Hassan, Sugar Land, Texas. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Use of a high shear mechanical device in a process for production of starch hydrolysate by reacting starch with a hydrolytic agent makes possible a decrease in mass transfer limitations, thereby enhancing production of starch hydrolysate. A system for production of starch hydrolysate is also provided in which a reactor is configured to receive the output from a high shear device, which is configured to receive a starch and lysing reagent. The high shear device is configured to generate a fine dispersion or emulsion of lysing." The patent application was filed on June 26, 2008 (12/146,733). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,672&OS=8,445,672&RS=8,445,672 Written by Arpi Sharma; edited by Anand Kumar. *** Lummus Technology Assigned Patent ALEXANDRIA, Va., May 24 -- Lummus Technology, Bloomfield, N.J., has been assigned a patent (8,445,740) developed by Stephen J. Stanley, Matawan, N.J., Stephen De Haan, Wayne, N.J., and Peter Daniel Kuzma Jr., Bloomingdale, N.J., for an "absorber demethanizer for FCC process." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A process for recovering ethylene is disclosed, the process including: recovering a ethylene-containing stream comprising methane, ethylene, and nitrogen oxides from at least one of an ethylene production process and an ethylene recovery process; separating the ethylene-containing stream via extractive distillation using at least one C.sub.2+ hydrocarbon absorbent to produce an overheads fraction comprising methane and nitrogen oxides and a bottoms fraction comprising the at least one C.sub.2+ hydrocarbon absorbent and ethylene; wherein the separating comprises operating the extractive distillation at temperatures and pressures sufficient to prevent any substantial conversion of nitrogen oxides to N.sub.2O.sub.3." The patent application was filed on Nov. 23, 2010 (12/952,952). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,740&OS=8,445,740&RS=8,445,740 Written by Arpi Sharma; edited by Anand Kumar. *** ExxonMobil Chemical Patents Assigned Patent ALEXANDRIA, Va., May 24 -- ExxonMobil Chemical Patents, Houston, has been assigned a patent (8,445,730) developed by four co-inventors for a "process for producing phenol." The co-inventors are Jihad M. Dakka, Whitehouse Station, N.J., Kun Wang, Bridgewater, N.J., Edmund J. Mozeleski, Califon, N.J., and Stephen Zushma, Clinton, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "In a process for producing phenol or a substituted phenol, an alkylaromatic hydroperoxide having a general formula (I): ##STR00001## in which R.sup.1 and R.sup.2 each independently represents an alkyl group having from 1 to 4 carbon atoms, provided that R.sup.1 and R.sup.2 may be joined to form a cyclic group having from 4 to 10 carbon atoms, said cyclic group being optionally substituted, and R.sup.3 represents hydrogen, one or more alkyl groups having from 1 to 4 carbon atoms or a cyclohexyl group, is contacted with a catalyst comprising an oxide of at least one metal from Groups 3 to 5 and Groups 7 to 14 of the Periodic Table of the Elements and an oxide of at least one metal from Group 6 of the Periodic Table of the Elements." The patent application was filed on July 14, 2009 (13/061,601). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,445,730&OS=8,445,730&RS=8,445,730 Written by Arpi Sharma; edited by Anand Kumar. For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; [email protected]; http://targetednews.com. -1126103 (c) 2013 Targeted News Service |